Prostate cancer drug that can halve death risk to be offered to thousands in England
At least 6,000 men a year with hormone-sensitive cancer to get access to darolutamide, which blocks growth with fewer side-effects Thousands of men with advanced prostate cancer in England are to be offered a drug that can halve the risk of death. In guidance published on Friday, the National (…)
Site référencé:
The Guardian (South&CentralAsia)
3333.jpg?width=140&quality=85&auto=format&fit=max&s=4ef98f38f4c778416f19eff8a360aecc, 3333.jpg?width=460&quality=85&auto=format&fit=max&s=1150db78d91fedf560db661d7de6d353, 3333.jpg?width=700&quality=85&auto=format&fit=max&s=b88b50e1202d2797417341d7e43a97ab
The Guardian (South&CentralAsia)
Louvre thieves’ slow-motion getaway using furniture lift was caught on video
23/10/2025
Palestine rights group seeks prosecution of UK citizens who fought for Israel
23/10/2025
Ben Jennings on Labour and Brexit – cartoon
23/10/2025
Five grooming gang survivors tell PM they will stay on panel only if Jess Phillips remains in post
23/10/2025
Dinosaurs were thriving until asteroid struck, research suggests
23/10/2025
The Guardian view on Conservative immigration policy : the threat of mass expulsions is abhorrent | Editorial
23/10/2025